Skip to main content
Top
Published in: BMC Geriatrics 1/2020

Open Access 01-12-2020 | Underweight | Research article

Accuracy of diagnosis and health service codes in identifying frailty in Medicare data

Authors: Natalia Festa, Sandra M. Shi, Dae Hyun Kim

Published in: BMC Geriatrics | Issue 1/2020

Login to get access

Abstract

Background

Capturing frailty within administrative claims data may help to identify high-risk patients and inform population health management strategies. Although it is common to ascertain frailty status utilizing claims-based surrogates (e.g. diagnosis and health service codes) selected according to clinical knowledge, the accuracy of this approach has not yet been examined. We evaluated the accuracy of claims-based surrogates against two clinical definitions of frailty.

Methods

This cross-sectional study was conducted in a Health and Retirement Study subsample of 3097 participants, aged 65 years or older and with at least 12-months of continuous fee-for-service Medicare enrollment. We defined 18 previously utilized claims-based surrogates of frailty from Medicare data and evaluated each against clinical reference standards, ascertained from a direct examination: a deficit accumulation frailty index (FI) (range: 0–1) and frailty phenotype. We also compared the accuracy of the total count of 18 claims-based surrogates with that of a validated claims-based FI model, comprised of 93 claims-based variables.

Results

19% of participants met clinical criteria for the clinical frailty phenotype. The mean clinical FI for our sample was 0.20 (standard deviation 0.13). Hospital Beds and associated supplies was the claims-based surrogate associated with the highest clinical FI (mean FI 0.49). Claims-based surrogates had low sensitivity ranging from 0.01 (cachexia, adult failure to thrive, anorexia) to 0.38 (malaise and fatigue) and high specificity ranging from 0.79 (malaise and fatigue) to 0.99 (cachexia, adult failure to thrive, anorexia) in discriminating the clinical frailty phenotype. Compared with a validated claims-based FI, the total count of claims-based surrogates demonstrated lower Spearman correlation with the clinical FI (0.41 [95% CI 0.38–0.44] versus 0.59 [95% CI, 0.56–0.61]) and poorer discrimination of the frailty phenotype (C-statistics 0.68 [95% CI, 0.66–0.70] versus 0.75 [95% CI, 0.73–0.77]).

Conclusions

Claims-based surrogates, selected according to clinical knowledge, do not accurately capture frailty in Medicare claims data. A simple count of claims-based surrogates improves accuracy but remains inferior to a claims-based FI model.
Appendix
Available only for authorised users
Literature
1.
go back to reference Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. Untangling the concepts of disability, Frailty, and comorbidity: implications for improved targeting and care. J Gerontol Ser A Biol Sci Med Sci. 2004;59(3):M255–63.CrossRef Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. Untangling the concepts of disability, Frailty, and comorbidity: implications for improved targeting and care. J Gerontol Ser A Biol Sci Med Sci. 2004;59(3):M255–63.CrossRef
5.
go back to reference Morley JE, Vellas B, Abellan van Kan G, Anker SD, Bauer JM, Bernabei R, et al. Frailty consensus: A call to action. J Am Med Dir Assoc. 2013;14(6):392–7.CrossRef Morley JE, Vellas B, Abellan van Kan G, Anker SD, Bauer JM, Bernabei R, et al. Frailty consensus: A call to action. J Am Med Dir Assoc. 2013;14(6):392–7.CrossRef
6.
go back to reference Kidd T, Mold F, Jones C, Ream E, Grosvenor W, Sund-Levander M, et al. What are the most effective interventions to improve physical performance in pre-frail and frail adults? A systematic review of randomised control trials. BMC Geriatr; 2019. 19 p. 184. https://bmcgeriatr.biomedcentral.com/articles/https://doi.org/10.1186/s12877-019-1196-x [cited 2020 Apr 20]. BioMed Central Ltd. Kidd T, Mold F, Jones C, Ream E, Grosvenor W, Sund-Levander M, et al. What are the most effective interventions to improve physical performance in pre-frail and frail adults? A systematic review of randomised control trials. BMC Geriatr; 2019. 19 p. 184. https://​bmcgeriatr.​biomedcentral.​com/​articles/​https://​doi.​org/​10.​1186/​s12877-019-1196-x [cited 2020 Apr 20]. BioMed Central Ltd.
7.
go back to reference Hoogendijk EO, Afilalo J, Ensrud KE, Kowal P, Onder G, Fried LP. Frailty: implications for clinical practice and public health. Lancet. 2019;394:1365–75 Lancet Publishing Group.CrossRef Hoogendijk EO, Afilalo J, Ensrud KE, Kowal P, Onder G, Fried LP. Frailty: implications for clinical practice and public health. Lancet. 2019;394:1365–75 Lancet Publishing Group.CrossRef
17.
go back to reference Kim DH, Glynn RJ, Avorn J, Lipsitz LA, Rockwood K, Pawar A, et al. Validation of a Claims-Based Frailty Index Against Physical Performance and Adverse Health Outcomes in the Health and Retirement Study. J Gerontol A Biol Sci Med Sci. 2019;74(8):1271–6 Available from: http://www.ncbi.nlm.nih.gov/pubmed/30165612 [cited 2020 Apr 20].CrossRef Kim DH, Glynn RJ, Avorn J, Lipsitz LA, Rockwood K, Pawar A, et al. Validation of a Claims-Based Frailty Index Against Physical Performance and Adverse Health Outcomes in the Health and Retirement Study. J Gerontol A Biol Sci Med Sci. 2019;74(8):1271–6 Available from: http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​30165612 [cited 2020 Apr 20].CrossRef
21.
22.
go back to reference Soong J, Poots AJ, Scott S, Donald K, Woodcock T, Lovett D, et al. Quantifying the prevalence of frailty in English hospitals. BMJ Open. 2015;5(10):e008456.CrossRef Soong J, Poots AJ, Scott S, Donald K, Woodcock T, Lovett D, et al. Quantifying the prevalence of frailty in English hospitals. BMJ Open. 2015;5(10):e008456.CrossRef
27.
go back to reference Kim DH, Patorno E, Pawar A, Lee H, Schneeweiss S, Glynn RJ. Measuring Frailty in Administrative Claims Data: Comparative Performance of Four Claims-Based Frailty Measures in the United States Medicare Data. J Gerontol A Biol Sci Med Sci. 2019; Available from: http://www.ncbi.nlm.nih.gov/pubmed/31566201 [cited 2020 Apr 20]. Kim DH, Patorno E, Pawar A, Lee H, Schneeweiss S, Glynn RJ. Measuring Frailty in Administrative Claims Data: Comparative Performance of Four Claims-Based Frailty Measures in the United States Medicare Data. J Gerontol A Biol Sci Med Sci. 2019; Available from: http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​31566201 [cited 2020 Apr 20].
29.
go back to reference Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol Ser A Biol Sci Med Sci. 2001;56(3):M146–57.CrossRef Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol Ser A Biol Sci Med Sci. 2001;56(3):M146–57.CrossRef
30.
go back to reference Rockwood K, Mitnitski A. Frailty in relation to the accumulation of deficits. J Gerontol S A Biol Sci Med Sci. 2007;62:722–7 Gerontological Society of America.CrossRef Rockwood K, Mitnitski A. Frailty in relation to the accumulation of deficits. J Gerontol S A Biol Sci Med Sci. 2007;62:722–7 Gerontological Society of America.CrossRef
Metadata
Title
Accuracy of diagnosis and health service codes in identifying frailty in Medicare data
Authors
Natalia Festa
Sandra M. Shi
Dae Hyun Kim
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2020
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-020-01739-w

Other articles of this Issue 1/2020

BMC Geriatrics 1/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.